Alpha 2.0
Login Register
» Articles » PMID: 11264140

Cyclodiode Laser Therapy for Painful, Blind Glaucomatous Eyes

Overview
Journal Br J Ophthalmol
Specialty Ophthalmology
Date 2001 Mar 27
PMID 11264140
Citations 10
Authors
K R Martin
D C Broadway
Affiliations
Soon will be listed here.
Abstract

Aims: To determine the ability of cyclodiode laser treatment to relieve discomfort in painful blind glaucomatous eyes.

Methods: 30 eyes underwent cyclodiode to reduce intraocular pressure (IOP) and relieve pain. Patients graded their pre-cyclodiode and post-cyclodiode pain.

Results: After a minimum follow up of 6 months, a single cyclodiode treatment lowered mean IOP from 51 mm Hg (95% CI plus or minus 3.7 mm Hg) to 26 mm Hg (95% CI plus or minus 5.8 mm Hg) providing pain relief in 73.3% (22/30). After retreatment of six eyes, mean IOP was reduced to 22 (95% CI plus or minus 5.3) mm Hg and pain relief was obtained in 96.7% (29/30). For eyes achieving pain relief after one treatment, IOP was reduced by >30% in 81.0% (17/21). For eyes not achieving pain relief after one treatment, IOP was reduced by >30% in only 22.2% (2/9) (p=0.0042, Fisher's exact test).

Conclusion: Cyclodiode was highly successful in providing pain relief in painful blind hypertensive glaucomatous eyes. The best predictor of successful pain relief was IOP reduction of > 30% from baseline.

Citing Articles

Severe Corneal Melt Post Trans-Scleral Cyclodiode in a Case of Neovascular Glaucoma Secondary to Coats Disease: A Case Report.

Lee J, Chan G, Shahid H Case Rep Ophthalmol. 2023; 14(1):513-518.

PMID: 37901631 PMC: 10601846. DOI: 10.1159/000534104.

Micropulse diode laser therapy in refractory glaucoma.

Issiaka M, Zrikem K, Mchachi A, Benhmidoune L, Rachid R, Belhadji M Adv Ophthalmol Pract Res. 2023; 3(1):23-28.

PMID: 37846428 PMC: 10577867. DOI: 10.1016/j.aopr.2022.10.003.

Painful-blind eye: A forgotten palliative care.

Parra-Tanoux D, Dussan-Vargas M, Escandon M Indian J Ophthalmol. 2023; 71(6):2399-2408.

PMID: 37322649 PMC: 10417970. DOI: 10.4103/IJO.IJO_3063_22.

Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation.

Lenzhofer M, Hohensinn M, Hitzl W, Steiner V, Motaabbed A, Motloch K Graefes Arch Clin Exp Ophthalmol. 2021; 259(8):2351-2361.

PMID: 33797631 PMC: 8352832. DOI: 10.1007/s00417-021-05157-5.

Transscleral Diode Laser Cyclophotocoagulation: A Comparison of Slow Coagulation and Standard Coagulation Techniques.

Duerr E, Sayed M, Moster S, Holley T, Peiyao J, Vanner E Ophthalmol Glaucoma. 2020; 1(2):115-122.

PMID: 32632402 PMC: 7337205. DOI: 10.1016/j.ogla.2018.08.007.

References
1.
Hawkins T, Stewart W . One-year results of semiconductor transscleral cyclophotocoagulation in patients with glaucoma. Arch Ophthalmol. 1993; 111(4):488-91. DOI: 10.1001/archopht.1993.01090040080035. View
2.
Sabri K, Vernon S . Scleral perforation following trans-scleral cyclodiode. Br J Ophthalmol. 1999; 83(4):502-3. PMC: 1723018. DOI: 10.1136/bjo.83.4.501c. View
3.
Todd K, Funk K, FUNK J, Bonacci R . Clinical significance of reported changes in pain severity. Ann Emerg Med. 1996; 27(4):485-9. DOI: 10.1016/s0196-0644(96)70238-x. View
4.
Kosoko O, Gaasterland D, POLLACK I, Enger C . Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The Diode Laser Ciliary Ablation Study Group. Ophthalmology. 1996; 103(8):1294-302. DOI: 10.1016/s0161-6420(96)30508-3. View
5.
Yarnitsky D, Sprecher E, Zaslansky R, Hemli J . Multiple session experimental pain measurement. Pain. 1996; 67(2-3):327-33. DOI: 10.1016/0304-3959(96)03110-7. View